research Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
Ritlecitinib provides new treatment options for diverse alopecia areata patients.
Search
forProducts matching "pfizer"
Tracking 1 products like 313 Loniten (minoxidil) 2.5mg tablets front Loniten (minoxidil) 2.5mg tablets back Loniten (minoxidil) 2.5mg tablets from by companies like oxfordon line pharmacy. View product »
Sort by
Research
480-510 / 765 results 
research Side Effects of Low-Dose Oral Minoxidil for Treating Alopecia
Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.
research Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.
research Low-Dose Oral Minoxidil Improves Hair Length and Global Hair Density in Short Anagen Syndrome
Low-dose minoxidil helps hair grow longer and thicker in people with short anagen syndrome.
research Long-Term Efficacy of Baricitinib in the Treatment of Alopecia Areata: Results at Week 104 from the BRAVE-AA1 and BRAVE-AA2 Studies
Baricitinib effectively treats severe alopecia for up to 104 weeks.
research New-Onset Systemic Lupus Erythematosus Beginning as Class V Lupus Nephritis After COVID-19 Vaccination
COVID-19 vaccination may trigger lupus in some people.
research Exacerbation of Subacute Cutaneous Lupus Erythematosus Following Vaccination with BNT162b2 mRNA Vaccine
COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.
research Does Increased Interest in Oral Minoxidil After Media Attention Apply to Non-English-Speaking Patients?
More research is needed to see if non-English speakers are also more interested in oral minoxidil.
research Tofacitinib Treatment of Inflammatory Skin Conditions in Patients With Down Syndrome
Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.
research Reversibility of Alopecia Caused by Chronic Cutaneous Lupus Erythematosus
Hair loss from chronic cutaneous lupus erythematosus can sometimes be reversed with early, aggressive treatment.
research Obstetrician/Gynecologist
I'm sorry, but there's not enough information to provide a summary.
research Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.
research Sex Differences in Arterial Hypertension
Women may need different blood pressure guidelines than men for heart disease prevention.
research JAK Inhibition in the Treatment of Alopecia Areata: A Promising New Dawn?
JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.
research Management of Chemotherapy-Induced Alopecia With Scalp Cooling
Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.
research Safety and Efficacy of the COVID-19 Vaccine in Children and Adolescents: A Meta-Analysis
COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.
research Systematic Review of Newer Agents for the Management of Alopecia Areata in Adults: Janus Kinase Inhibitors, Biologics and Phosphodiesterase-4 Inhibitors
New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.
research Methotrexate Treatment of Generalized Granuloma Annulare: A Retrospective Case Series
Methotrexate improved skin condition in 64% of patients with generalized granuloma annulare.
research Janus Kinase Inhibitors for Alopecia Areata
JAK inhibitors offer new hope for treating severe alopecia areata.
research Low-Dose Oral Minoxidil Increases Hair Density and Thickness in Androgenetic Alopecia: A Retrospective Analysis of 60 Patients
Low-dose oral minoxidil increases hair density and thickness in people with hair loss.
research Alopecia – New Building Blocks
New treatments for hair loss are emerging, and doctors need to learn how to use them effectively.
research The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: A Narrative Review
People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.
research Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from India
Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.
research Reproductive System, Male: Biology of Spermatogenesis and Toxicology
The document explains how sperm cells are produced, the role of testosterone in this process, and how toxins can reduce sperm count and fertility.
research Approach to the Patient With Hair Loss
The guide helps dermatologists diagnose and treat different types of hair loss.
research A Practical Approach to the Management of Hair Loss in Patients With Polycystic Ovary Syndrome
The article concludes that more research is needed on how to diagnose and treat hair loss in women with polycystic ovary syndrome.
research Response to the Article 'Evaluation of Standardized Scalp Photography on Patient Perception of Hair Loss Severity, Anxiety, and Treatment'
Combining scalp photos with hair density and caliber measurements gives a more accurate assessment of hair loss.
research Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.
research Treatment of Traction Alopecia with Oral Minoxidil
Oral minoxidil helped significantly regrow hair in a patient with traction alopecia.
research A Scoping Review of Alopecia Areata and Its Relationship to COVID-19 Vaccinations
COVID-19 vaccines do not increase the risk of alopecia areata.